Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 04:03 ET | Source: Research and Markets

Artificial Intelligence (AI) Model Watermarking Global Market Research Report 2025 with Long-term Prospects to 2029 and 2034

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) Model Watermarking Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The artificial...
January 08, 2026 04:02 ET | Source: Research and Markets

Scaffolding Industry Report 2025: Infrastructure Projects, Urbanization, and Smart City Initiatives Fuel Demand - Long-term Forecast to 2029 and 2034

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Scaffolding Market Report 2025" has been added to ResearchAndMarkets.com's offering. The scaffolding market is experiencing robust growth, with...
January 08, 2026 04:01 ET | Source: Xinhuanet North America Corporation

Global mayors' dialogue in Harbin charts course for sustainable winter economy

HARBIN, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- According to Xinhuanet, which participated in the event’s coverage throughout all stages, the “Global Mayors Dialogue in Harbin” opened on January 6...
January 08, 2026 04:01 ET | Source: Research and Markets

Last-Mile Drone Delivery of Inputs Global Market Report 2025-2029 and 2034: Tech Advancements, Emerging Markets, and Precision Agriculture Adoption Bolster Expansion

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Last-Mile Drone Delivery of Inputs Global Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The last-mile drone delivery...
January 08, 2026 04:00 ET | Source: Oculis Holding AG

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones...
January 08, 2026 04:00 ET | Source: Wolters Kluwer N.V.

Share Buyback Transaction Details January 2 – January 7, 2026

PRESS RELEASE Share Buyback Transaction Details January 2 – January 7, 2026 Alphen aan den Rijn – January 8, 2026 - Wolters Kluwer (Euronext: WKL), a global...
January 08, 2026 04:00 ET | Source: NRG Therapeutics Limited

NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s

STEVENAGE, United Kingdom, Jan. 08, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial dysfunction in...
January 08, 2026 04:00 ET | Source: Oculis Holding AG

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

ZUG, Switzerland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market...
January 08, 2026 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors

VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina”), a biopharmaceutical company advancing innovative cancer therapies...
January 08, 2026 04:00 ET | Source: EnteroBiotix

EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome

Clinically meaningful improvements in global IBS symptom severity observed as early as Week 1 and sustained through Week 7, with EBX-102-02 outperforming placebo throughout the study (final assessment...

1 ...530 531 532 ...316300